^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    cusatuzumab (ARGX-110)

    i
    Company:
    OncoVerity, argenx
    Drug class:
    CD70 inhibitor
    Related drugs: